Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : SA Surpasses 21 Million Administered Covid-19 Vaccine Doses

10/22/2021 | 08:06am EST

South Africa has now passed the 21 million mark for total COVID-19 jabs administered since the start of the country's vaccination rollout programme.

This comes after 205 253 doses were distributed in the past 24 hours, pushing the total to 21 011 187 doses administered to 14 568 927 people.

The Department of Health's data shows that the Western Cape is leading the race so far, with 45.38% of its adults having received at least one dose of the jab, followed by 42.60% in Free State, 42.16% in Limpopo and 41.88% in the Eastern Cape.

In addition, the latest statistics indicate that 11 346 972 adults are now fully jabbed, with 149 492 either having received the single-shot Johnson & Johnson vaccine or the second dose of Pfizer on Thursday.

Meanwhile, the National Institute for Communicable Diseases (NICD) said 31 913 tests were conducted in the last 24 hours, with 520 new cases, representing a 1.6% positivity rate.

KwaZulu-Natal accounted for 100 new infections, followed by 89 cases in the Western Cape, 74 in Gauteng, 71 in the Northern Cape, 69 in the Free State, 39 in the North West, 34 in the Eastern Cape, 32 in Mpumalanga and 12 in Limpopo.

In addition, the country lost 81 more people to the disease, bringing the death toll to 88 835 since the outbreak.

"The proportion of positive new cases... is 1.6%, which is lower than Wednesday's 1.7%," the NICD explained, adding that the seven-day moving average daily number of cases has decreased.

According to the institute, there were 62 hospital admissions since the last reporting cycle.

This means there are now 4 413 patients who are receiving treatment for COVID-19 in various hospitals across the country, of which 1 836 are admitted at public hospitals.

In addition, by the end of Thursday, the department said almost 69 000 children between the ages of 12 and 17 registered to receive the vaccine, while over 13 000 of them were vaccinated with one dose of the Pfizer vaccine.

According to the World Health Organisation, as of 21 October 2021, there have been 241 886 635 confirmed cases of COVID-19, 4 919 755 deaths and 6 655 399 359 administered vaccine doses.

Copyright SAnews.gov.za. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

All news about PFIZER, INC.
07:00aHow worried should we be about the Omicron variant?
RE
01:10aPARENTING IN A PANDEMIC : To Vaccinate Or Not To Vaccinate?
AQ
11/26ADRs Close Lower; BioNTech Rises, Carnival Drops
DJ
11/26US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New COVID-19 Stra..
MT
11/26CLOSE UPDATE : US Stocks, Treasury Yields Sink With Crude Oil as Concern Mounts Over New C..
MT
11/26FTSE 100 Closes Friday Down as Latest Coronavirus Variant Sparks Sell-off
DJ
11/26Covid-19 Vaccine Maker Stocks Higher Amid Variant Concerns
DJ
11/26New purchase in the MarketScreener USA Portfolio
11/26FDA Places Clinical Hold on Phase 3 Study for Ocugen COVID-19 Vaccine Covaxin
MT
11/26Pfizer Up Over 6%, on Track for Record High Close -- Data Talk
DJ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 529 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 827 M - -
P/E ratio 2021 13,9x
Yield 2021 2,92%
Capitalization 303 B 303 B -
EV / Sales 2021 4,06x
EV / Sales 2022 3,97x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,00 $
Average target price 48,53 $
Spread / Average Target -10,1%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.46.70%303 095
JOHNSON & JOHNSON1.82%419 109
ROCHE HOLDING AG16.05%336 162
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049
ABBVIE INC.8.74%205 976